Now that Congress has been unable to pass legislation capping the monthly cost of insulin for non-Medicare patients at $35, alternative solutions need to be found for this serious, increasing problem. A survey of 199 insulin-requiring people with diabetes published in 2019 revealed that one-fourth of respondents were underusing insulin because of costs, and these individuals were three times more likely to have an A1C level >9.0% than those who were able to take their prescribed insulin doses (1). The 2021 National Health Interview carried out by the Centers for Disease Control and Prevention revealed that >1 million Americans ration insulin (2). A survey of 2,000 individuals using insulin published in 2022 by Charity Rx revealed that 62% underused insulin, 80% took on credit card debt averaging $9,000 to afford their average $400 monthly cost of insulin, and 38% had a hospital admission for ≥1 day...

You do not currently have access to this content.